Like alpha-glucosidase, alpha-amylase is an enzyme that breaks down larger sugars and starches into smaller molecules that can be rapidly absorbed
These include improving vascular function, reducing systemic inflammation, enhancing coronary microvascular function, and mitigating comorbid conditions like metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic kidney disease (CKD)
thus, there appeared to be an additional direct psychological effect of GLP-1 receptor agonists, rather than the weight loss per se
Key details regarding the July 2026 review: July 23, 2026 Review: BPC-157 (wound/injury), KPV (inflammation), TB-500 (wound healing), and MOTs-C (obesity/osteoporosis)
The more effective medication depends on your individual needs